Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

FDA approval of Nemluvio covers use of the drug ... Starting Jan. 2, the company’s stock symbol on the Nasdaq will be “ONC.” —Applied Therapeutics received a double dose of bad regulatory ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Previously, the FDA had approved Tevimbra as a single agent and ... its name to BeOne Medicines and switch its Nasdaq ticker symbol to “ONC” on January 2, 2025.